Top

Published in:

01-06-2019 | Breast Cancer

Na⁺,HCO₃⁻ cotransporter NBCn1 accelerates breast carcinogenesis

Author: Ebbe Boedtkjer

Published in: Cancer and Metastasis Reviews | Issue 1-2/2019

Abstract

Cell metabolism increases during carcinogenesis. Yet, intracellular pH in solid cancer tissue is typically maintained equal to or above that of normal tissue. This is achieved through accelerated cellular acid extrusion that compensates for the enhanced metabolic acid production. Upregulated Na⁺,HCO₃⁻ cotransport is the predominant mechanism of net acid extrusion in human and murine breast cancer tissue, and in congruence, the protein expression of the electroneutral Na⁺,HCO₃⁻ cotransporter NBCn1 is increased in primary breast carcinomas and lymph node metastases compared to matched normal breast tissue. The capacity for net acid extrusion and level of steady-state intracellular pH are lower in carcinogen- and ErbB2-induced breast cancer tissue from NBCn1 knockout mice compared to wild-type mice. Consistent with importance of intracellular pH control for breast cancer development, tumor-free survival is prolonged and tumor growth rate decelerated in NBCn1 knockout mice compared to wild-type mice. Glycolytic activity increases as function of tumor size and in areas of poor oxygenation. Because cell proliferation in NBCn1 knockout mice is particularly reduced in larger-sized breast carcinomas and central tumor regions with expected hypoxia, current evidence supports that NBCn1 facilitates cancer progression by eliminating intracellular acidic waste products derived from cancer cell metabolism. The present review explores the mechanisms and consequences of acid-base regulation in breast cancer tissue. Emphasis is on the Na⁺,HCO₃⁻ cotransporter NBCn1 that accelerates net acid extrusion from breast cancer tissue and thereby maintains intracellular pH in a range permissive for cell proliferation and development of breast cancer.

Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646–674. https://doi.org/10.1016/j.cell.2011.02.013.CrossRefPubMed

Robergs, R. A., Ghiasvand, F., & Parker, D. (2004). Biochemistry of exercise-induced metabolic acidosis. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 287(3), R502–R516. https://doi.org/10.1152/ajpregu.00114.2004.CrossRefPubMed

Mookerjee, S. A., Goncalves, R. L., Gerencser, A. A., Nicholls, D. G., & Brand, M. D. (2015). The contributions of respiration and glycolysis to extracellular acid production. Biochimica et Biophysica Acta, 1847(2), 171–181. https://doi.org/10.1016/j.bbabio.2014.10.005.CrossRefPubMed

Potter, M., Newport, E., & Morten, K. J. (2016). The Warburg effect: 80 years on. Biochemical Society Transactions, 44(5), 1499–1505. https://doi.org/10.1042/BST20160094.CrossRefPubMedPubMedCentral

Gatenby, R. A., & Gillies, R. J. (2004). Why do cancers have high aerobic glycolysis? Nature Reviews. Cancer, 4(11), 891–899. https://doi.org/10.1038/nrc1478.CrossRefPubMed

Cairns, R. A., Harris, I. S., & Mak, T. W. (2011). Regulation of cancer cell metabolism. Nature Reviews. Cancer, 11(2), 85–95. https://doi.org/10.1038/nrc2981.CrossRefPubMed

Vaupel, P., Kallinowski, F., & Okunieff, P. (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Research, 49(23), 6449–6465.PubMed

Junttila, M. R., & de Sauvage, F. J. (2013). Influence of tumour micro-environment heterogeneity on therapeutic response. Nature, 501, 346–354. https://doi.org/10.1038/nature12626.CrossRefPubMed

Castañeda-Gill, J. M., & Vishwanatha, J. K. (2016). Antiangiogenic mechanisms and factors in breast cancer treatment. Journal of Carcinogenesis, 15, 1. https://doi.org/10.4103/1477-3163.176223.CrossRefPubMedPubMedCentral

10.

Froelunde, A. S., Ohlenbusch, M., Hansen, K. B., Jessen, N., Kim, S., & Boedtkjer, E. (2018). Murine breast cancer feed arteries are thin-walled with reduced α_1A-adrenoceptor expression and attenuated sympathetic vasocontraction. Breast Cancer Research, 20(1), 20. https://doi.org/10.1186/s13058-018-0952-8.CrossRefPubMed

11.

Voss, N., Kold-Petersen, H., & Boedtkjer, E. (2018). Enhanced nitric oxide signaling amplifies vasorelaxation of human colon cancer feed arteries. American Journal of Physiology. Heart and Circulatory Physiology, 316, H245–H254. https://doi.org/10.1152/ajpheart.00368.2018.CrossRefPubMed

12.

Fidelman, M. L., Seeholzer, S. H., Walsh, K. B., & Moore, R. D. (1982). Intracellular pH mediates action of insulin on glycolysis in frog skeletal muscle. The American Journal of Physiology, 242(1), C87–C93. https://doi.org/10.1152/ajpcell.1982.242.1.C87.CrossRefPubMed

13.

Trivedi, B., & Danforth, W. H. (1966). Effect of pH on the kinetics of frog muscle phosphofructokinase. The Journal of Biological Chemistry, 241(17), 4110–4112.PubMed

14.

Pedersen, S. F. (2006). The Na⁺/H⁺ exchanger NHE1 in stress-induced signal transduction: implications for cell proliferation and cell death. Pflügers Archiv, 452(3), 249–259. https://doi.org/10.1007/s00424-006-0044-y.CrossRefPubMed

15.

Caldwell, P. (1958). Studies on the internal pH of large muscle and nerve fibres. The Journal of Physiology, 142(1), 22–62. https://doi.org/10.1113/jphysiol.1958.sp005998.CrossRefPubMedPubMedCentral

16.

Boedtkjer, E., Moreira, J. M., Mele, M., Vahl, P., Wielenga, V. T., Christiansen, P. M., et al. (2013). Contribution of Na⁺,HCO₃ ⁻-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7). International Journal of Cancer, 132(6), 1288–1299. https://doi.org/10.1002/ijc.27782.CrossRefPubMed

17.

Lee, S., Mele, M., Vahl, P., Christiansen, P. M., Jensen, V. E. D., & Boedtkjer, E. (2015). Na⁺,HCO₃ ⁻-cotransport is functionally upregulated during human breast carcinogenesis and required for the inverted pH gradient across the plasma membrane. Pflügers Archiv, 467(2), 367–377. https://doi.org/10.1007/s00424-014-1524-0.CrossRefPubMed

18.

Lee, S., Axelsen, T. V., Andersen, A. P., Vahl, P., Pedersen, S. F., & Boedtkjer, E. (2016). Disrupting Na⁺,HCO₃ ⁻-cotransporter NBCn1 (Slc4a7) delays murine breast cancer development. Oncogene, 35(16), 2112–2122. https://doi.org/10.1038/onc.2015.273.CrossRefPubMed

19.

Bhujwalla, Z. M., Aboagye, E. O., Gillies, R. J., Chacko, V. P., Mendola, C. E., & Backer, J. M. (1999). Nm23-transfected MDA-mB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a ³¹P nuclear magnetic resonance study in vivo and in vitro. Magnetic Resonance in Medicine, 41(5), 897–903. https://doi.org/10.1002/(SICI)1522-2594(199905)41:5<897::AID-MRM7>3.0.CO;2-T.CrossRefPubMed

20.

Raghunand, N., Altbach, M. I., van Sluis, R., Baggett, B., Taylor, C. W., Bhujwalla, Z. M., & Gillies, R. J. (1999). Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by ³¹P magnetic resonance spectroscopy. Biochemical Pharmacology, 57(3), 309–312. https://doi.org/10.1016/S0006-2952(98)00306-2.CrossRefPubMed

21.

De Milito, A., Marino, M. L., & Fais, S. (2012). A rationale for the use of proton pump inhibitors as antineoplastic agents. Current Pharmaceutical Design, 18(10), 1395–1406. https://doi.org/10.2174/138161212799504911.CrossRefPubMed

22.

Chiche, J., Le, F. Y., Vilmen, C., Frassineti, F., Daniel, L., Halestrap, A. P., et al. (2012). In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH. International Journal of Cancer, 130(7), 1511–1520. https://doi.org/10.1002/ijc.26125.CrossRefPubMed

23.

Aalkjaer, C., Boedtkjer, E., Choi, I., & Lee, S. (2014). Cation-coupled bicarbonate transporters. Comprehensive Physiology, 4(4), 1605–1637. https://doi.org/10.1002/cphy.c130005.CrossRefPubMedPubMedCentral

24.

Gorbatenko, A., Olesen, C. W., Boedtkjer, E., & Pedersen, S. F. (2014). Regulation and roles of bicarbonate transporters in cancer. Frontiers in Physiology, 5, 130. https://doi.org/10.3389/fphys.2014.00130.CrossRefPubMedPubMedCentral

25.

Choi, I., Aalkjaer, C., Boulpaep, E. L., & Boron, W. F. (2000). An electroneutral sodium/bicarbonate cotransporter NBCn1 and associated sodium channel. Nature, 405(6786), 571–575. https://doi.org/10.1038/35014615.CrossRefPubMed

26.

Gross, E., Hawkins, K., Abuladze, N., Pushkin, A., Cotton, C. U., Hopfer, U., & Kurtz, I. (2001). The stoichiometry of the electrogenic sodium bicarbonate cotransporter NBC1 is cell-type dependent. The Journal of Physiology, 531(Pt 3), 597–603. https://doi.org/10.1111/j.1469-7793.2001.0597h.x.CrossRefPubMedPubMedCentral

27.

Millar, I. D., & Brown, P. D. (2008). NBCe2 exhibits a 3 HCO₃ ⁻:1 Na⁺ stoichiometry in mouse choroid plexus epithelial cells. Biochemical and Biophysical Research Communications, 373(4), 550–554. https://doi.org/10.1016/j.bbrc.2008.06.053.CrossRefPubMed

28.

Virkki, L. V., Wilson, D. A., Vaughan-Jones, R. D., & Boron, W. F. (2002). Functional characterization of human NBC4 as an electrogenic Na⁺-HCO₃ ⁻ cotransporter (NBCe2). American Journal of Physiology Cell Physiology, 282(6), C1278–C1289. https://doi.org/10.1152/ajpcell.00589.2001.CrossRefPubMed

29.

Gross, E., Fedotoff, O., Pushkin, A., Abuladze, N., Newman, D., & Kurtz, I. (2003). Phosphorylation-induced modulation of pNBC1 function: distinct roles for the amino- and carboxy-termini. The Journal of Physiology, 549(Pt 3), 673–682. https://doi.org/10.1113/jphysiol.2003.042226.CrossRefPubMedPubMedCentral

30.

Gross, E., Hawkins, K., Pushkin, A., Sassani, P., Dukkipati, R., Abuladze, N., Hopfer, U., & Kurtz, I. (2001). Phosphorylation of Ser⁹⁸² in the sodium bicarbonate cotransporter kNBC1 shifts the HCO₃ ⁻: Na⁺ stoichiometry from 3:1 to 2:1 in murine proximal tubule cells. The Journal of Physiology, 537(Pt 3), 659–665. https://doi.org/10.1111/j.1469-7793.2001.00659.x.CrossRefPubMedPubMedCentral

31.

Virkki, L. V., Choi, I., Davis, B. A., & Boron, W. F. (2003). Cloning of a Na⁺-driven Cl/HCO₃ exchanger from squid giant fiber lobe. American Journal of Physiology. Cell Physiology, 285(4), C771–C780. https://doi.org/10.1152/ajpcell.00439.2002.CrossRefPubMed

32.

Grichtchenko, I. I., Choi, I., Zhong, X., Bray-Ward, P., Russell, J. M., & Boron, W. F. (2001). Cloning, characterization, and chromosomal mapping of a human electroneutral Na⁺-driven Cl-HCO₃ exchanger. The Journal of Biological Chemistry, 276(11), 8358–8363. https://doi.org/10.1074/jbc.C000716200.CrossRefPubMed

33.

Wang, C. Z., Yano, H., Nagashima, K., & Seino, S. (2000). The Na⁺-driven Cl^–/HCO₃ ⁻ exchanger. Cloning, tissue distribution, and functional characterization. The Journal of Biological Chemistry, 275(45), 35486–35490. https://doi.org/10.1074/jbc.C000456200.CrossRefPubMed

34.

Damkier, H. H., Aalkjaer, C., & Praetorius, J. (2010). Na⁺-dependent HCO₃ ⁻ import by the slc4a10 gene product involves Cl^– export. The Journal of Biological Chemistry, 285(35), 26998–27007. https://doi.org/10.1074/jbc.M110.108712.CrossRefPubMedPubMedCentral

35.

Parker, M. D., Musa-Aziz, R., Rojas, J. D., Choi, I., Daly, C. M., & Boron, W. F. (2008). Characterization of human SLC4A10 as an electroneutral Na/HCO₃ cotransporter (NBCn2) with Cl⁻ self-exchange activity. The Journal of Biological Chemistry, 283(19), 12777–12788. https://doi.org/10.1074/jbc.M707829200.CrossRefPubMedPubMedCentral

36.

Boron, W. F. (2010). Evaluating the role of carbonic anhydrases in the transport of HCO₃ ⁻-related species. Biochimica et Biophysica Acta, 1804(2), 410–421. https://doi.org/10.1016/j.bbapap.2009.10.021.CrossRefPubMed

37.

Seki, G., Coppola, S., Yoshitomi, K., Burckhardt, B.-C., Samarzija, I., Müller-Berger, S., & Frömter, E. (1996). On the mechanism of bicarbonate exit from renal proximal tubular cells. Kidney International, 49(6), 1671–1677. https://doi.org/10.1038/ki.1996.244.CrossRefPubMed

38.

Boedtkjer, E., Bunch, L., & Pedersen, S. F. (2012). Physiology, pharmacology and pathophysiology of the pH regulatory transport proteins NHE1 and NBCn1: Similarities, differences and implications for cancer therapy. Current Pharmaceutical Design, 18(10), 1345–1371. https://doi.org/10.2174/138161212799504830.CrossRefPubMed

39.

Boedtkjer, E., & Aalkjaer, C. (2009). Insulin inhibits Na⁺/H⁺ exchange in vascular smooth muscle and endothelial cells in situ: involvement of H₂O₂ and tyrosine phosphatase SHP-2. American Journal of Physiology. Heart and Circulatory Physiology, 296(2), H247–H255. https://doi.org/10.1152/ajpheart.00725.2008.CrossRefPubMed

40.

Boedtkjer, E., Damkier, H. H., & Aalkjaer, C. (2012). NHE1 knockout reduces blood pressure and arterial media/lumen ratio with no effect on resting pH_i in the vascular wall. The Journal of Physiology, 590(Pt 6), 1895–1906. https://doi.org/10.1113/jphysiol.2011.227132.CrossRefPubMedPubMedCentral

41.

Chen, Y., Choong, L. Y., Lin, Q., Philp, R., Wong, C. H., Ang, B. K., Tan, Y. L., Loh, M. C. S., Hew, C. L., Shah, N., Druker, B. J., Chong, P. K., & Lim, Y. P. (2007). Differential expression of novel tyrosine kinase substrates during breast cancer development. Molecular & Cellular Proteomics, 6(12), 2072–2087. https://doi.org/10.1074/mcp.M700395-MCP200.CrossRef

42.

Ahmed, S., Thomas, G., Ghoussaini, M., Healey, C. S., Humphreys, M. K., Platte, R., et al. (2009). Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nature Genetics, 41(5), 585–590. https://doi.org/10.1038/ng.354.CrossRefPubMedPubMedCentral

43.

Long, J., Shu, X. O., Cai, Q., Gao, Y. T., Zheng, Y., Li, G., Li, C., Gu, K., Wen, W., Xiang, Y. B., Lu, W., & Zheng, W. (2010). Evaluation of breast cancer susceptibility loci in chinese women. Cancer Epidemiology, Biomarkers & Prevention, 19(9), 2357–2365. https://doi.org/10.1158/1055-9965.EPI-10-0054.CrossRef

44.

go back to reference Antoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., Neuhausen, S. L., Ding, Y. C., Rebbeck, T. R., Weitzel, J. N., Lynch, H. T., Isaacs, C., Ganz, P. A., Tomlinson, G., Olopade, O. I., Couch, F. J., Wang, X., Lindor, N. M., Pankratz, V. S., Radice, P., Manoukian, S., Peissel, B., Zaffaroni, D., Barile, M., Viel, A., Allavena, A., Dall’Olio, V., Peterlongo, P., Szabo, C. I., Zikan, M., Claes, K., Poppe, B., Foretova, L., Mai, P. L., Greene, M. H., Rennert, G., Lejbkowicz, F., Glendon, G., Ozcelik, H., Andrulis, I. L., for the Ontario Cancer Genetics Network, Thomassen, M., Gerdes, A. M., Sunde, L., Cruger, D., Birk Jensen, U., Caligo, M., Friedman, E., Kaufman, B., Laitman, Y., Milgrom, R., Dubrovsky, M., Cohen, S., Borg, A., Jernstrom, H., Lindblom, A., Rantala, J., Stenmark-Askmalm, M., Melin, B., for SWE-BRCA, Nathanson, K., Domchek, S., Jakubowska, A., Lubinski, J., Huzarski, T., Osorio, A., Lasa, A., Duran, M., Tejada, M. I., Godino, J., Benitez, J., Hamann, U., Kriege, M., Hoogerbrugge, N., van der Luijt, R. B., Asperen, C. J., Devilee, P., Meijers-Heijboer, E. J., Blok, M. J., Aalfs, C. M., Hogervorst, F., Rookus, M., for HEBON, Cook, M., Oliver, C., Frost, D., Conroy, D., Evans, D. G., Lalloo, F., Pichert, G., Davidson, R., Cole, T., Cook, J., Paterson, J., Hodgson, S., Morrison, P. J., Porteous, M. E., Walker, L., Kennedy, M. J., Dorkins, H., Peock, S., for EMBRACE, Godwin, A. K., Stoppa-Lyonnet, D., de Pauw, A., Mazoyer, S., Bonadona, V., Lasset, C., Dreyfus, H., Leroux, D., Hardouin, A., Berthet, P., Faivre, L., for GEMO, Loustalot, C., Noguchi, T., Sobol, H., Rouleau, E., Nogues, C., Frenay, M., Venat-Bouvet, L., for GEMO, Hopper, J. L., Daly, M. B., Terry, M. B., John, E. M., Buys, S. S., Yassin, Y., Miron, A., Goldgar, D., for the Breast Cancer Family Registry, Singer, C. F., Dressler, A. C., Gschwantler-Kaulich, D., Pfeiler, G., Hansen, T. V. O., Jonson, L., Agnarsson, B. A., Kirchhoff, T., Offit, K., Devlin, V., Dutra-Clarke, A., Piedmonte, M., Rodriguez, G. C., Wakeley, K., Boggess, J. F., Basil, J., Schwartz, P. E., Blank, S. V., Toland, A. E., Montagna, M., Casella, C., Imyanitov, E., Tihomirova, L., Blanco, I., Lazaro, C., Ramus, S. J., Sucheston, L., Karlan, B. Y., Gross, J., Schmutzler, R., Wappenschmidt, B., Engel, C., Meindl, A., Lochmann, M., Arnold, N., Heidemann, S., Varon-Mateeva, R., Niederacher, D., Sutter, C., Deissler, H., Gadzicki, D., Preisler-Adams, S., Kast, K., Schonbuchner, I., Caldes, T., de la Hoya, M., Aittomaki, K., Nevanlinna, H., Simard, J., Spurdle, A. B., Holland, H., Chen, X., for kConFab, Platte, R., Chenevix-Trench, G., Easton, D. F., & on behalf of CIMBA. (2010). Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Research, 70(23), 9742–9754. https://doi.org/10.1158/0008-5472.can-10-1907.CrossRefPubMedPubMedCentral Antoniou, A. C., Beesley, J., McGuffog, L., Sinilnikova, O. M., Healey, S., Neuhausen, S. L., Ding, Y. C., Rebbeck, T. R., Weitzel, J. N., Lynch, H. T., Isaacs, C., Ganz, P. A., Tomlinson, G., Olopade, O. I., Couch, F. J., Wang, X., Lindor, N. M., Pankratz, V. S., Radice, P., Manoukian, S., Peissel, B., Zaffaroni, D., Barile, M., Viel, A., Allavena, A., Dall’Olio, V., Peterlongo, P., Szabo, C. I., Zikan, M., Claes, K., Poppe, B., Foretova, L., Mai, P. L., Greene, M. H., Rennert, G., Lejbkowicz, F., Glendon, G., Ozcelik, H., Andrulis, I. L., for the Ontario Cancer Genetics Network, Thomassen, M., Gerdes, A. M., Sunde, L., Cruger, D., Birk Jensen, U., Caligo, M., Friedman, E., Kaufman, B., Laitman, Y., Milgrom, R., Dubrovsky, M., Cohen, S., Borg, A., Jernstrom, H., Lindblom, A., Rantala, J., Stenmark-Askmalm, M., Melin, B., for SWE-BRCA, Nathanson, K., Domchek, S., Jakubowska, A., Lubinski, J., Huzarski, T., Osorio, A., Lasa, A., Duran, M., Tejada, M. I., Godino, J., Benitez, J., Hamann, U., Kriege, M., Hoogerbrugge, N., van der Luijt, R. B., Asperen, C. J., Devilee, P., Meijers-Heijboer, E. J., Blok, M. J., Aalfs, C. M., Hogervorst, F., Rookus, M., for HEBON, Cook, M., Oliver, C., Frost, D., Conroy, D., Evans, D. G., Lalloo, F., Pichert, G., Davidson, R., Cole, T., Cook, J., Paterson, J., Hodgson, S., Morrison, P. J., Porteous, M. E., Walker, L., Kennedy, M. J., Dorkins, H., Peock, S., for EMBRACE, Godwin, A. K., Stoppa-Lyonnet, D., de Pauw, A., Mazoyer, S., Bonadona, V., Lasset, C., Dreyfus, H., Leroux, D., Hardouin, A., Berthet, P., Faivre, L., for GEMO, Loustalot, C., Noguchi, T., Sobol, H., Rouleau, E., Nogues, C., Frenay, M., Venat-Bouvet, L., for GEMO, Hopper, J. L., Daly, M. B., Terry, M. B., John, E. M., Buys, S. S., Yassin, Y., Miron, A., Goldgar, D., for the Breast Cancer Family Registry, Singer, C. F., Dressler, A. C., Gschwantler-Kaulich, D., Pfeiler, G., Hansen, T. V. O., Jonson, L., Agnarsson, B. A., Kirchhoff, T., Offit, K., Devlin, V., Dutra-Clarke, A., Piedmonte, M., Rodriguez, G. C., Wakeley, K., Boggess, J. F., Basil, J., Schwartz, P. E., Blank, S. V., Toland, A. E., Montagna, M., Casella, C., Imyanitov, E., Tihomirova, L., Blanco, I., Lazaro, C., Ramus, S. J., Sucheston, L., Karlan, B. Y., Gross, J., Schmutzler, R., Wappenschmidt, B., Engel, C., Meindl, A., Lochmann, M., Arnold, N., Heidemann, S., Varon-Mateeva, R., Niederacher, D., Sutter, C., Deissler, H., Gadzicki, D., Preisler-Adams, S., Kast, K., Schonbuchner, I., Caldes, T., de la Hoya, M., Aittomaki, K., Nevanlinna, H., Simard, J., Spurdle, A. B., Holland, H., Chen, X., for kConFab, Platte, R., Chenevix-Trench, G., Easton, D. F., & on behalf of CIMBA. (2010). Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Research, 70(23), 9742–9754. https://doi.org/10.1158/0008-5472.can-10-1907.CrossRefPubMedPubMedCentral

45.

Milne, R. L., Gaudet, M. M., Spurdle, A. B., Fasching, P. A., Couch, F. J., Benítez, J., et al. (2010). Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Research, 12(6), 1–11. https://doi.org/10.1186/bcr2797.CrossRef

46.

Han, W., Woo, J. H., Yu, J. H., Lee, M. J., Moon, H. G., Kang, D., & Noh, D. Y. (2011). Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiology, Biomarkers & Prevention, 20(5), 793–798. https://doi.org/10.1158/1055-9965.EPI-10-1282.CrossRef

47.

Peng, S., Lü, B., Ruan, W., Zhu, Y., Sheng, H., & Lai, M. (2011). Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. Breast Cancer Research and Treatment, 127(2), 309–324. https://doi.org/10.1007/s10549-011-1459-5.CrossRefPubMed

48.

Campa, D., Kaaks, R., Le Marchand, L., Haiman, C. A., Travis, R. C., Berg, C. D., et al. (2011). Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. Journal of the National Cancer Institute, 103(16), 1252–1263. https://doi.org/10.1093/jnci/djr265.CrossRefPubMedPubMedCentral

49.

Sueta, A., Ito, H., Kawase, T., Hirose, K., Hosono, S., Yatabe, Y., Tajima, K., Tanaka, H., Iwata, H., Iwase, H., & Matsuo, K. (2012). A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Research and Treatment, 132(2), 711–721. https://doi.org/10.1007/s10549-011-1904-5.CrossRefPubMed

50.

Chen, W., Zhong, R., Ming, J., Zou, L., Zhu, B., Lu, X., Ke, J., Zhang, Y., Liu, L., Miao, X., & Huang, T. (2012). The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case-control study and a meta-analysis. Breast Cancer Research and Treatment, 136(3), 847–857. https://doi.org/10.1007/s10549-012-2309-9.CrossRefPubMed

51.

Warren Andersen, S., Trentham-Dietz, A., Gangnon, R. E., Hampton, J. M., Figueroa, J. D., Skinner, H. G., Engelman, C. D., Klein, B. E., Titus, L. J., & Newcomb, P. A. (2013). The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk. Breast Cancer Research and Treatment, 140(2), 427–434. https://doi.org/10.1007/s10549-013-2646-3.CrossRefPubMed

52.

Han, M.-R., Deming-Halverson, S., Cai, Q., Wen, W., Shrubsole, M. J., Shu, X.-O., Zheng, W., & Long, J. (2015). Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study. Breast Cancer, 22(5), 544–551. https://doi.org/10.1007/s12282-014-0518-2.CrossRefPubMed

53.

Mulligan, A. M., Couch, F. J., Barrowdale, D., Domchek, S. M., Eccles, D., Nevanlinna, H., et al. (2011). Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2. Breast Cancer Research, 13(6), R110. https://doi.org/10.1186/bcr3052.CrossRefPubMed

54.

Fernandez-Navarro, P., Pita, G., Santamarina, C., Moreno, M. P., Vidal, C., Miranda-Garcia, J., et al. (2013). Association analysis between breast cancer genetic variants and mammographic density in a large population-based study (Determinants of Density in Mammographies in Spain) identifies susceptibility loci in TOX3 gene. European Journal of Cancer, 49(2), 474–481. https://doi.org/10.1016/j.ejca.2012.08.026.CrossRefPubMed

55.

Fasching, P. A., Pharoah, P. D. P., Cox, A., Nevanlinna, H., Bojesen, S. E., Karn, T., Broeks, A., van Leeuwen, F. E., van ’t Veer, L. J., Udo, R., Dunning, A. M., Greco, D., Aittomäki, K., Blomqvist, C., Shah, M., Nordestgaard, B. G., Flyger, H., Hopper, J. L., Southey, M. C., Apicella, C., Garcia-Closas, M., Sherman, M., Lissowska, J., Seynaeve, C., Huijts, P. E. A., Tollenaar, R. A. E. M., Ziogas, A., Ekici, A. B., Rauh, C., Mannermaa, A., Kataja, V., Kosma, V. M., Hartikainen, J. M., Andrulis, I. L., Ozcelik, H., Mulligan, A. M., Glendon, G., Hall, P., Czene, K., Liu, J., Chang-Claude, J., Wang-Gohrke, S., Eilber, U., Nickels, S., Dörk, T., Schiekel, M., Bremer, M., Park-Simon, T. W., Giles, G. G., Severi, G., Baglietto, L., Hooning, M. J., Martens, J. W. M., Jager, A., Kriege, M., Lindblom, A., Margolin, S., Couch, F. J., Stevens, K. N., Olson, J. E., Kosel, M., Cross, S. S., Balasubramanian, S. P., Reed, M. W. R., Miron, A., John, E. M., Winqvist, R., Pylkäs, K., Jukkola-Vuorinen, A., Kauppila, S., Burwinkel, B., Marme, F., Schneeweiss, A., Sohn, C., Chenevix-Trench, G., kConFab Investigators, Lambrechts, D., Dieudonne, A. S., Hatse, S., van Limbergen, E., Benitez, J., Milne, R. L., Zamora, M. P., Pérez, J. I. A., Bonanni, B., Peissel, B., Loris, B., Peterlongo, P., Rajaraman, P., Schonfeld, S. J., Anton-Culver, H., Devilee, P., Beckmann, M. W., Slamon, D. J., Phillips, K. A., Figueroa, J. D., Humphreys, M. K., Easton, D. F., & Schmidt, M. K. (2012). The role of genetic breast cancer susceptibility variants as prognostic factors. Human Molecular Genetics, 21(17), 3926–3939. https://doi.org/10.1093/hmg/dds159.CrossRefPubMedPubMedCentral

56.

Wang, L., Li, H., Yang, B., Guo, L., Han, X., Li, L., Li, M., Huang, J., & Gu, D. (2017). The hypertension risk variant rs820430 functions as an enhancer of SLC4A7. American Journal of Hypertension, 30(2), 202–208. https://doi.org/10.1093/ajh/hpw127.CrossRefPubMed

57.

Ng, F. L., Boedtkjer, E., Witkowska, K., Ren, M., Zhang, R., Tucker, A., Aalkjær, C., Caulfield, M. J., & Ye, S. (2017). Increased NBCn1 expression, Na⁺/HCO₃ ⁻ co-transport and intracellular pH in human vascular smooth muscle cells with a risk allele for hypertension. Human Molecular Genetics, 26(5), 989–1002. https://doi.org/10.1093/hmg/ddx015.CrossRefPubMedPubMedCentral

58.

Lauritzen, G., Jensen, M. B., Boedtkjer, E., Dybboe, R., Aalkjaer, C., Nylandsted, J., et al. (2010). NBCn1 and NHE1 expression and activity in ΔNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pH_i regulation and chemotherapy resistance. Experimental Cell Research, 316(15), 2538–2553. https://doi.org/10.1016/j.yexcr.2010.06.005.CrossRefPubMed

59.

Scaltriti, M., Rojo, F., Ocaña, A., Anido, J., Guzman, M., Cortes, J., et al. (2007). Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer. Journal of the National Cancer Institute, 99(8), 628–638. https://doi.org/10.1093/jnci/djk134.CrossRefPubMed

60.

Sáez, R., Molina, M. A., Ramsey, E. E., Rojo, F., Keenan, E. J., Albanell, J., Lluch, A., García-Conde, J., Baselga, J., & Clinton, G. M. (2006). p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer. Clinical Cancer Research, 12(2), 424–431. https://doi.org/10.1158/1078-0432.ccr-05-1807.CrossRefPubMed

61.

Andersen, A. P., Samsøe-Petersen, J., Oernbo, E. K., Boedtkjer, E., Moreira, J. M. A., Kveiborg, M., et al. (2018). The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms. International Journal of Cancer, 142(12), 2529–2542. https://doi.org/10.1002/ijc.31276.CrossRefPubMed

62.

Larsen, A. M., Krogsgaard-Larsen, N., Lauritzen, G., Olesen, C. W., Honoré Hansen, S., Boedtkjer, E., et al. (2012). Gram-scale solution-phase synthesis of selective sodium bicarbonate co-transport inhibitor S0859: in vitro efficacy studies in breast cancer cells. ChemMedChem, 7(10), 1808–1814. https://doi.org/10.1002/cmdc.201200335.CrossRefPubMed

63.

Steinkamp, A.-D., Seling, N., Lee, S., Boedtkjer, E., & Bolm, C. (2015). Synthesis of N-cyano-substituted sulfilimine and sulfoximine derivatives of S0859 and their biological evaluation as sodium bicarbonate co-transport inhibitors. MedChemComm, 6(12), 2163–2169. https://doi.org/10.1039/C5MD00367A.CrossRef

64.

Lee, S., Axelsen, T. V., Jessen, N., Pedersen, S. F., Vahl, P., & Boedtkjer, E. (2018). Na⁺,HCO₃ ⁻-cotransporter NBCn1 (Slc4a7) accelerates ErbB2-induced breast cancer development and tumor growth in mice. Oncogene, 37(41), 5569–5584. https://doi.org/10.1038/s41388-018-0353-6.CrossRefPubMed

65.

Rotin, D., Steele-Norwood, D., Grinstein, S., & Tannock, I. (1989). Requirement of the Na⁺/H⁺ exchanger for tumor growth. Cancer Research, 49(1), 205–211.PubMed

66.

Pouyssegur, J., Franchi, A., & Pages, G. (2001). pH_i, aerobic glycolysis and vascular endothelial growth factor in tumour growth. Novartis Foundation Symposium, 240, 186–196.PubMed

67.

Busco, G., Cardone, R. A., Greco, M. R., Bellizzi, A., Colella, M., Antelmi, E., Mancini, M. T., Dell’Aquila, M. E., Casavola, V., Paradiso, A., & Reshkin, S. J. (2010). NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space. The FASEB Journal, 24(10), 3903–3915. https://doi.org/10.1096/fj.09-149518.CrossRefPubMed

68.

Stüwe, L., Müller, M., Fabian, A., Waning, J., Mally, S., Noël, J., Schwab, A., & Stock, C. (2007). pH dependence of melanoma cell migration: protons extruded by NHE1 dominate protons of the bulk solution. The Journal of Physiology, 585(2), 351–360. https://doi.org/10.1113/jphysiol.2007.145185.CrossRefPubMedPubMedCentral

69.

Fais, S., De Milito, A., You, H., & Qin, W. (2007). Targeting vacuolar H⁺-ATPases as a new strategy against cancer. Cancer Research, 67(22), 10627–10630. https://doi.org/10.1158/0008-5472.CAN-07-1805.CrossRefPubMed

70.

Chiche, J., Ricci, J. E., & Pouyssegur, J. (2013). Tumor hypoxia and metabolism—towards novel anticancer approaches. Annales d'endocrinologie, 74(2), 111–114. https://doi.org/10.1016/j.ando.2013.02.004.CrossRefPubMed

71.

Morais-Santos, F., Granja, S., Miranda-Goncalves, V., Moreira, A. H. J., Queiros, S., Vilaca, J. L., et al. (2015). Targeting lactate transport suppresses in vivo breast tumour growth. Oncotarget, 6(22), 19177–19189. https://doi.org/10.18632/oncotarget.3910.CrossRefPubMedPubMedCentral

72.

Dovmark, T. H., Saccomano, M., Hulikova, A., Alves, F., & Swietach, P. (2017). Connexin-43 channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells. Oncogene, 36, 4538–4550. https://doi.org/10.1038/onc.2017.71.CrossRefPubMedPubMedCentral

73.

Dovmark, T. H., Hulikova, A., Niederer, S. A., Vaughan-Jones, R. D., & Swietach, P. (2018). Normoxic cells remotely regulate the acid-base balance of cells at the hypoxic core of connexin-coupled tumor growths. The FASEB Journal, 32(1), 83–96. https://doi.org/10.1096/fj.201700480R.CrossRefPubMed

74.

Hulikova, A., Black, N., Hsia, L.-T., Wilding, J., Bodmer, W. F., & Swietach, P. (2016). Stromal uptake and transmission of acid is a pathway for venting cancer cell-generated acid. Proceedings of the National Academy of Sciences of the United States of America, 113(36), E5344–E5353. https://doi.org/10.1073/pnas.1610954113.CrossRefPubMedPubMedCentral

75.

Bonde, L., & Boedtkjer, E. (2017). Extracellular acidosis and very low [Na⁺] inhibit NBCn1- and NHE1-mediated net acid extrusion from mouse vascular smooth muscle cells. Acta Physiologica (Oxford, England), 219, 227–238. https://doi.org/10.1111/apha.12877.CrossRef

76.

Hulikova, A., Vaughan-Jones, R. D., & Swietach, P. (2011). Dual role of CO₂/HCO₃ ⁻ buffer in the regulation of intracellular pH of three-dimensional tumor growths. The Journal of Biological Chemistry, 286(16), 13815–13826. https://doi.org/10.1074/jbc.M111.219899.CrossRefPubMedPubMedCentral

77.

Swietach, P., Patiar, S., Supuran, C. T., Harris, A. L., & Vaughan-Jones, R. D. (2009). The role of carbonic anhydrase 9 in regulating extracellular and intracellular pH in three-dimensional tumor cell growths. The Journal of Biological Chemistry, 284(30), 20299–20310. https://doi.org/10.1074/jbc.M109.006478.CrossRefPubMedPubMedCentral

78.

Chiche, J., Ilc, K., Laferrière, J., Trottier, E., Dayan, F., Mazure, N. M., et al. (2009). Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Research, 69(1), 358–368. https://doi.org/10.1158/0008-5472.can-08-2470.CrossRefPubMed

79.

van Kuijk, S. J. A., Yaromina, A., Houben, R., Niemans, R., Lambin, P., & Dubois, L. J. (2016). Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis. Frontiers in Oncology, 6, 69. https://doi.org/10.3389/fonc.2016.00069.CrossRefPubMedPubMedCentral

80.

Zhao, Z., Liao, G., Li, Y., Zhou, S., Zou, H., & Fernando, S. (2014). Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature. PLoS One, 9(11), e114096. https://doi.org/10.1371/journal.pone.0114096.CrossRefPubMedPubMedCentral

81.

Peridis, S., Pilgrim, G., Athanasopoulos, I., & Parpounas, K. (2011). Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis. European Archives of Oto-Rhino-Laryngology, 268(5), 661–670. https://doi.org/10.1007/s00405-011-1488-z.CrossRefPubMed

82.

Ilie, M. I., Hofman, V., Ortholan, C., Ammadi, R. E., Bonnetaud, C., Havet, K., Venissac, N., Mouroux, J., Mazure, N. M., Pouysségur, J., & Hofman, P. (2011). Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis. International Journal of Cancer, 128(7), 1614–1623. https://doi.org/10.1002/ijc.25491.CrossRefPubMed

83.

Deitmer, J. W., & Becker, H. M. (2013). Transport metabolons with carbonic anhydrases. Frontiers in Physiology, 4, 291. https://doi.org/10.3389/fphys.2013.00291.CrossRefPubMedPubMedCentral

84.

Loiselle, F. B., Morgan, P. E., Alvarez, B. V., & Casey, J. R. (2004). Regulation of the human NBC3 Na⁺/HCO₃ ⁻ cotransporter by carbonic anhydrase II and PKA. American Journal of Physiology Cell Physiology, 286(6), C1423–C1433. https://doi.org/10.1152/ajpcell.00382.2003.CrossRefPubMed

85.

Alvarez, B. V., Loiselle, F. B., Supuran, C. T., Schwartz, G. J., & Casey, J. R. (2003). Direct extracellular interaction between carbonic anhydrase IV and the human NBC1 sodium/bicarbonate co-transporter. Biochemistry, 42(42), 12321–12329. https://doi.org/10.1021/bi0353124.CrossRefPubMed

86.

Li, X., Alvarez, B., Casey, J. R., Reithmeier, R. A. F., & Fliegel, L. (2002). Carbonic anhydrase II binds to and enhances activity of the Na⁺/H⁺ exchanger. The Journal of Biological Chemistry, 277(39), 36085–36091. https://doi.org/10.1074/jbc.M111952200.CrossRefPubMed

87.

Klier, M., Andes, F. T., Deitmer, J. W., & Becker, H. M. (2014). Intracellular and extracellular carbonic anhydrases cooperate non-enzymatically to enhance activity of monocarboxylate transporters. The Journal of Biological Chemistry, 289(5), 2765–2775. https://doi.org/10.1074/jbc.M113.537043.CrossRefPubMed

88.

Piermarini, P. M., Kim, E. Y., & Boron, W. F. (2007). Evidence against a direct interaction between intracellular carbonic anhydrase II and pure C-terminal domains of SLC4 bicarbonate transporters. The Journal of Biological Chemistry, 282(2), 1409–1421. https://doi.org/10.1074/jbc.M608261200.CrossRefPubMed

89.

Reithmeier, R. A. F. (2001). A membrane metabolon linking carbonic anhydrase with chloride/bicarbonate anion exchangers. Blood Cells, Molecules & Diseases, 27(1), 85–89. https://doi.org/10.1006/bcmd.2000.0353.CrossRef

90.

Becker, H. M., Klier, M., & Deitmer, J. W. (2014). Carbonic anhydrases and their interplay with acid/base-coupled membrane transporters. In S. C. Frost & R. McKenna (Eds.), Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications (pp. 105–134). Dordrecht: Springer Netherlands.CrossRef

91.

Al-Samir, S., Papadopoulos, S., Scheibe, R. J., Meißner, J. D., Cartron, J.-P., Sly, W. S., et al. (2013). Activity and distribution of intracellular carbonic anhydrase II and their effects on the transport activity of anion exchanger AE1/SLC4A1. The Journal of Physiology, 591(20), 4963–4982. https://doi.org/10.1113/jphysiol.2013.251181.CrossRefPubMedPubMedCentral

92.

Villafuerte, F. C., Swietach, P., Youm, J.-B., Ford, K., Cardenas, R., Supuran, C. T., Cobden, P. M., Rohling, M., & Vaughan-Jones, R. D. (2014). Facilitation by intracellular carbonic anhydrase of Na⁺–HCO₃ ⁻ co-transport but not Na⁺/H⁺ exchange activity in the mammalian ventricular myocyte. The Journal of Physiology, 592(5), 991–1007. https://doi.org/10.1113/jphysiol.2013.265439.CrossRefPubMedPubMedCentral

93.

Junge, W., & McLaughlin, S. (1987). The role of fixed and mobile buffers in the kinetics of proton movement. Biochimica et Biophysica Acta, 890(1), 1–5. https://doi.org/10.1016/0005-2728(87)90061-2.CrossRefPubMed

94.

Spitzer, K. W., Skolnick, R. L., Peercy, B. E., Keener, J. P., & Vaughan-Jones, R. D. (2002). Facilitation of intracellular H⁺ ion mobility by CO₂/HCO₃ ⁻ in rabbit ventricular myocytes is regulated by carbonic anhydrase. The Journal of Physiology, 541(Pt 1), 159–167. https://doi.org/10.1113/jphysiol.2001.013268.CrossRefPubMedPubMedCentral

95.

Cardone, R. A., Casavola, V., & Reshkin, S. J. (2005). The role of disturbed pH dynamics and the Na⁺/H⁺ exchanger in metastasis. Nature Reviews. Cancer, 5(10), 786–795. https://doi.org/10.1038/nrc1713.CrossRefPubMed

96.

Domschke, C., Schneeweiss, A., Stefanovic, S., Wallwiener, M., Heil, J., Rom, J., Sohn, C., Beckhove, P., & Schuetz, F. (2016). Cellular immune responses and immune escape mechanisms in breast cancer: determinants of immunotherapy. Breast Care, 11(2), 102–107. https://doi.org/10.1159/000446061.CrossRefPubMedPubMedCentral

97.

Lardner, A. (2001). The effects of extracellular pH on immune function. Journal of Leukocyte Biology, 69(4), 522–530. https://doi.org/10.1189/jlb.69.4.522.CrossRefPubMed

98.

Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., Tuccitto, A., Tagliabue, E., Castelli, C., & Rivoltini, L. (2017). Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation. Seminars in Cancer Biology, 43, 74–89. https://doi.org/10.1016/j.semcancer.2017.03.001.CrossRefPubMed

99.

De Milito, A., & Fais, S. (2005). Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncology, 1(6), 779–786. https://doi.org/10.2217/14796694.1.6.779.CrossRefPubMed

100.

Robey, I. F., Baggett, B. K., Kirkpatrick, N. D., Roe, D. J., Dosescu, J., Sloane, B. F., Hashim, A. I., Morse, D. L., Raghunand, N., Gatenby, R. A., & Gillies, R. J. (2009). Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Research, 69(6), 2260–2268. https://doi.org/10.1158/0008-5472.can-07-5575.CrossRefPubMedPubMedCentral

101.

Silva, A. S., Yunes, J. A., Gillies, R. J., & Gatenby, R. A. (2009). The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Research, 69(6), 2677–2684. https://doi.org/10.1158/0008-5472.CAN-08-2394.CrossRefPubMedPubMedCentral

102.

Robey, I. F., & Nesbit, L. A. (2013). Investigating mechanisms of alkalinization for reducing primary breast tumor invasion. BioMed Research International, 2013, 485196–485110. https://doi.org/10.1155/2013/485196.CrossRefPubMedPubMedCentral

103.

Ibrahim-Hashim, A., Robertson-Tessi, M., Enriquez-Navas, P. M., Damaghi, M., Balagurunathan, Y., Wojtkowiak, J. W., Russell, S., Yoonseok, K., Lloyd, M. C., Bui, M. M., Brown, J. S., Anderson, A. R. A., Gillies, R. J., & Gatenby, R. A. (2017). Defining cancer subpopulations by adaptive strategies rather than molecular properties provides novel insights into intratumoral evolution. Cancer Research, 77(9), 2242–2254. https://doi.org/10.1158/0008-5472.can-16-2844.CrossRefPubMedPubMedCentral

104.

Walker, R. A. (2001). The complexities of breast cancer desmoplasia. Breast Cancer Research, 3(3), 143. https://doi.org/10.1186/bcr287.CrossRefPubMedPubMedCentral

105.

Senthebane, D. A., Rowe, A., Thomford, N. E., Shipanga, H., Munro, D., Mazeedi, M. A. M. A., Almazyadi, H. A. M., Kallmeyer, K., Dandara, C., Pepper, M. S., Parker, M. I., & Dzobo, K. (2017). The role of tumor microenvironment in chemoresistance: to survive, keep your enemies closer. International Journal of Molecular Sciences, 18(7), 1586. https://doi.org/10.3390/ijms18071586.CrossRefPubMedCentral

106.

Castells, M., Thibault, B., Delord, J.-P., & Couderc, B. (2012). Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death. International Journal of Molecular Sciences, 13(8), 9545–9571. https://doi.org/10.3390/ijms13089545.CrossRefPubMedPubMedCentral

107.

Ferrero, E., Labalde, M., Fernández, N., Monge, L., Salcedo, A., Narvaez-Sanchez, R., Hidalgo, M., Dieguez, G., & García-Villalon, A. L. (2008). Response to endothelin-1 in arteries from human colorectal tumours: role of endothelin receptors. Experimental Biology and Medicine (Maywood, N.J.), 233(12), 1602–1607. https://doi.org/10.3181/0802-rm-69.CrossRef

108.

Aalkjaer, C., Boedtkjer, D., & Matchkov, V. (2011). Vasomotion—what is currently thought? Acta Physiologica (Oxford, England), 202(3), 253–269. https://doi.org/10.1111/j.1748-1716.2011.02320.x.CrossRef

109.

Thomsen, A. B. K., Kim, S., Aalbaek, F., Aalkjaer, C., & Boedtkjer, E. (2014). Intracellular acidification alters myogenic responsiveness and vasomotion of mouse middle cerebral arteries. Journal of Cerebral Blood Flow and Metabolism, 34(1), 161–168. https://doi.org/10.1038/jcbfm.2013.192.CrossRefPubMed

110.

Eigenbrodt, E., Kallinowski, F., Ott, M., Mazurek, S., & Vaupel, P. (1998). Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Research, 18(5A), 3267–3274.PubMed

111.

Pouysségur, J., Franchi, A., L’Allemain, G., & Paris, S. (1985). Cytoplasmic pH, a key determinant of growth factor-induced DNA synthesis in quiescent fibroblasts. FEBS Letters, 190(1), 115–119. https://doi.org/10.1016/0014-5793(85)80439-7.CrossRefPubMed

112.

Ober, S. S., & Pardee, A. B. (1987). Intracellular pH is increased after transformation of Chinese hamster embryo fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 84(9), 2766–2770. https://doi.org/10.1073/pnas.84.9.2766.CrossRefPubMedPubMedCentral

113.

Flinck, M., Kramer, S. H., Schnipper, J., Andersen, A. P., & Pedersen, S. F. (2018). The acid-base transport proteins NHE1 and NBCn1 regulate cell cycle progression in human breast cancer cells. Cell Cycle, 17(9), 1056–1067. https://doi.org/10.1080/15384101.2018.1464850.CrossRefPubMedPubMedCentral

114.

Seuwen, K., Ludwig, M. G., & Wolf, R. M. (2006). Receptors for protons or lipid messengers or both? Journal of Receptor and Signal Transduction Research, 26(5–6), 599–610. https://doi.org/10.1080/10799890600932220.CrossRefPubMed

115.

Damaghi, M., Wojtkowiak, J., & Gillies, R. (2013). pH sensing and regulation in cancer. Frontiers in Physiology, 4, 370. https://doi.org/10.3389/fphys.2013.00370.CrossRefPubMedPubMedCentral

116.

Chen, Y., Cann, M. J., Litvin, T. N., Iourgenko, V., Sinclair, M. L., Levin, L. R., & Buck, J. (2000). Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science, 289(5479), 625–628. https://doi.org/10.1126/science.289.5479.625.CrossRefPubMed

117.

Zhou, Y., Zhao, J., Bouyer, P., & Boron, W. F. (2005). Evidence from renal proximal tubules that HCO₃ ⁻ and solute reabsorption are acutely regulated not by pH but by basolateral HCO₃ ⁻ and CO₂. Proceedings of the National Academy of Sciences of the United States of America, 102(10), 3875–3880. https://doi.org/10.1073/pnas.0500423102.CrossRefPubMedPubMedCentral

118.

Boedtkjer, E., Hansen, K. B., Boedtkjer, D. M., Aalkjaer, C., & Boron, W. F. (2016). Extracellular HCO₃ ⁻ is sensed by mouse cerebral arteries: regulation of tone by receptor protein tyrosine phosphatase γ. Journal of Cerebral Blood Flow and Metabolism, 36, 965–980. https://doi.org/10.1177/0271678x15610787.CrossRefPubMed

119.

Stock, C., Cardone, R. A., Busco, G., Krahling, H., Schwab, A., & Reshkin, S. J. (2008). Protons extruded by NHE1: digestive or glue? European Journal of Cell Biology, 87(8–9), 591–599. https://doi.org/10.1016/j.ejcb.2008.01.007.CrossRefPubMed

120.

Boedtkjer, E., Bentzon, J. F., Dam, V. S., & Aalkjaer, C. (2016). Na⁺,HCO₃ ⁻-cotransporter NBCn1 increases pH_i gradients, filopodia and migration of smooth muscle cells and promotes arterial remodeling. Cardiovascular Research, 111(3), 227–239. https://doi.org/10.1093/cvr/cvw079.CrossRefPubMed

121.

Grinstein, S., Woodside, M., Waddell, T. K., Downey, G. P., Orlowski, J., Pouyssegur, J., Wong, D. C., & Foskett, J. K. (1993). Focal localization of the NHE-1 isoform of the Na⁺/H⁺ antiport: assessment of effects on intracellular pH. The EMBO Journal, 12(13), 5209–5218.CrossRef

122.

Stock, C., Mueller, M., Kraehling, H., Mally, S., Noel, J., Eder, C., et al. (2007). pH nanoenvironment at the surface of single melanoma cells. Cellular Physiology and Biochemistry, 20(5), 679–686. https://doi.org/10.1159/000107550.CrossRefPubMed

123.

Rofstad, E. K., Mathiesen, B., Kindem, K., & Galappathi, K. (2006). Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Research, 66(13), 6699–6707. https://doi.org/10.1158/0008-5472.can-06-0983.CrossRefPubMed

124.

Stock, C., Gassner, B., Hauck, C. R., Arnold, H., Mally, S., Eble, J. A., Dieterich, P., & Schwab, A. (2005). Migration of human melanoma cells depends on extracellular pH and Na⁺/H⁺ exchange. The Journal of Physiology, 567(Pt 1), 225–238. https://doi.org/10.1113/jphysiol.2005.088344.CrossRefPubMedPubMedCentral

125.

Lauritzen, G., Stock, C. M., Lemaire, J., Lund, S. F., Jensen, M. F., Damsgaard, B., Petersen, K. S., Wiwel, M., Rønnov-Jessen, L., Schwab, A., & Pedersen, S. F. (2012). The Na⁺/H⁺ exchanger NHE1, but not the Na⁺,HCO₃ ⁻ cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2. Cancer Letters, 317(2), 172–183. https://doi.org/10.1016/j.canlet.2011.11.023.CrossRefPubMed

126.

Svastova, E., Witarski, W., Csaderova, L., Kosik, I., Skvarkova, L., Hulikova, A., Zatovicova, M., Barathova, M., Kopacek, J., Pastorek, J., & Pastorekova, S. (2012). Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain. The Journal of Biological Chemistry, 287(5), 3392–3402. https://doi.org/10.1074/jbc.M111.286062.CrossRefPubMed

127.

Parks, S. K., & Pouyssegur, J. (2015). The Na⁺/HCO₃ ⁻ co-transporter SLC4A4 plays a role in growth and migration of colon and breast cancer cells. Journal of Cellular Physiology, 230(8), 1954–1963. https://doi.org/10.1002/jcp.24930.CrossRefPubMed

128.

McIntyre, A., Hulikova, A., Ledaki, I., Snell, C., Singleton, D., Steers, G., Seden, P., Jones, D., Bridges, E., Wigfield, S., Li, J. L., Russell, A., Swietach, P., & Harris, A. L. (2016). Disrupting hypoxia-induced bicarbonate transport acidifies tumor cells and suppresses tumor growth. Cancer Research, 76(13), 3744–3755. https://doi.org/10.1158/0008-5472.can-15-1862.CrossRefPubMed

129.

Kaluz, S., Kaluzová, M., Liao, S.-Y., Lerman, M., & Stanbridge, E. J. (2009). Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show? Biochimica et Biophysica Acta, 1795(2), 162–172. https://doi.org/10.1016/j.bbcan.2009.01.001.CrossRefPubMedPubMedCentral

130.

Dayan, F., Roux, D., Brahimi-Horn, M. C., Pouyssegur, J., & Mazure, N. M. (2006). The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1α. Cancer Research, 66(7), 3688–3698. https://doi.org/10.1158/0008-5472.can-05-4564.CrossRefPubMed

131.

Mrowiec, A. (2007). Localization and regulation of expression of the Na ⁺ ,HCO ₃ ⁻ -cotransporter NBCn1. PhD dissertation, Aarhus University, Denmark.

132.

Gorbatenko, A., Olesen, C. W., Morup, N., Thiel, G., Kallunki, T., Valen, E., et al. (2014). ErbB2 upregulates the Na⁺,HCO₃ ⁻-cotransporter NBCn1/SLC4A7 in human breast cancer cells via Akt, ERK, Src, and Kruppel-like factor 4. The FASEB Journal, 28(1), 350–363. https://doi.org/10.1096/fj.13-233288.CrossRefPubMed

133.

Orlowski, J., & Grinstein, S. (2011). Na⁺/H⁺ exchangers. Compr Physiol, 1(4), 2083–2100.PubMed

134.

Parker, M. D., & Boron, W. F. (2013). The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters. Physiological Reviews, 93(2), 803–959. https://doi.org/10.1152/physrev.00023.2012.CrossRefPubMedPubMedCentral

Title: Na+,HCO3− cotransporter NBCn1 accelerates breast carcinogenesis
Author: Ebbe Boedtkjer
Publication date: 01-06-2019
Publisher: Springer US
Keywords: Breast Cancer
Breast Cancer
Published in: Cancer and Metastasis Reviews / Issue 1-2/2019
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-019-09784-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1-2/2019

Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH

Cancer-associated mucins: role in immune modulation and metastasis

The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond

Extracellular acidity and increased exosome release as key phenotypes of malignant tumors

Cause and effect of microenvironmental acidosis on bone metastases

Correction to: mTOR co-targeting strategies for head and neck cancer therapy

Keynote webinar | Spotlight on antibody–drug conjugates in cancer